Skip to Main Content

Author Details

Xuexiang Zhang
Baruch S. Blumberg Institute
2005
15
13
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35061864A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.PLoS Pathog2022
30525438Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.ACS Infect Dis2019
31167838Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.Drug Metab Dispos2019
31060350Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.ACS Infect Dis2019
29253498Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.Antiviral Res2018
28982551A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.Antiviral Res2017
28197304Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction.ACS Med Chem Lett2017
27654301A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.J Virol2016
26597253The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.Clin Pharmacokinet2016
25605813Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.Drug Metab Dispos2015
24081303Acamprosate produces its anti-relapse effects via calcium.Neuropsychopharmacology2014
24646860Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.Kidney Int2014
23241029Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.J Med Chem2013
21920749Discovery of a novel potent GABA(B) receptor agonist.Bioorg Med Chem Lett2011
16287967Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.Proc Natl Acad Sci U S A2005
  • 1 - 15 of 15

Recommended Authors

UNC School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Gladstone Institutes
Career Start Year 2015
Number of shared co-authors 0
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2013
Number of shared co-authors 6
Anyang Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 2009
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Johns Hopkins School of Medicine
Career Start Year 2008
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
University of Minnesota
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1997
Number of shared co-authors 1
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 0
University of Dundee
Career Start Year 1995
Number of shared co-authors 1
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year 1994
Number of shared co-authors 0
Atux Iskay LLC
Career Start Year 1993
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Genomics Institute of the Novartis Research Foundation
Career Start Year 1992
Number of shared co-authors 0
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 0
Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
Division of Pharmacy and Optometry, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
Novartis
Career Start Year 1988
Number of shared co-authors 0
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0
University of Southampton Highfield Southampton SO17 1BJ UK.
Career Start Year 1986
Number of shared co-authors 0
Merck & Co. Inc.
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Collegeville
Co-authored papers 3
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 2
F. Hoffmann-La Roche Ltd.
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Roche Palo Alto LLC
Co-authored papers 2
Amunix Pharmaceuticals
Co-authored papers 1
Drug Metabolism and Pharmacokinetics
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Case Western Reserve University School of Medicine
Co-authored papers 1
Co-authored papers 1
Shionogi & Co.
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 1
Co-authored papers 1
Stanford University
Co-authored papers 1